Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.?
Chat live online
Select the?Live?Chat button at the bottom of the page?
Call us at?1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat.?We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
This photo from 快猫短视频 research grantee Andras Heczey, MD, shows a clear “win” from his phase 1 clinical trial of a new treatment for children who've been heavily treated for neuroblastoma.?
This photo shows a clear “win” from a? of a new treatment for children who have already been heavily treated for neuroblastoma. The photo was published in a study in?Nature Medicine?with co-authors and American Cancer Society (快猫短视频) research grantees Andras Heczey, MD, and Leonid Metelitsa, MD, PhD.
We’ve followed these studies at Baylor College of Medicine since Heczey received his first 快猫短视频 research grant in 2016. That’s when he was genetically adapting CAR T-Cell therapy to treat neuroblastoma. Later, on a , Heczey talked about his work with neuroblastoma (and with pediatric liver cancer). And, we reported on his progress when he initiated his experimental treatment’s first clinical trial.
These images are from updated interim phase 1 trial results published in At this phase, anti-tumor activity wasn’t the first goal, so it’s much too early to deem this new treatment a success. What researchers did conclude was:
?
? ??? ?
If this was helpful, donate to help fund patient support services, research, and cancer content updates.